Lv6
2720 积分 2021-12-12 加入
mRNA Cancer Vaccines: From Pandemic Paradigm to Personalized Oncology Therapeutics
3天前
已完结
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
6天前
已完结
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
6天前
已完结
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
6天前
已完结
CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy
17天前
已完结
ERAP-1 and ERAP-2 Variants in Liver Injury After COVID-19 mRNA Vaccination: A US Multicenter Study
27天前
已完结
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
1个月前
已完结
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
1个月前
已完结
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
1个月前
已完结
CD19-CAR T-cell therapy induces deep tissue depletion of B cells
2个月前
已完结
皖公网安备34019202002308
